Objective Visual vertical (VV) measurements are being increasingly used for routine clinical assessment of spatial cognition, to investigate otolithic vestibular function and identify altered verticality perception as a possible cause…
Objective Transit disorders are frequent in multiple sclerosis with an impact on the health related quality of life. However, just a few studies have been published on this subject. Moreover,…
Objective In stroke patients, motor impairments evaluated during the first few weeks usually predict upper limb motor outcomes after rehabilitation. However, a recent growing literature suggests that severe patients might…
Objective Active and intensive physical therapy (PT) facilitates motor recovery when provided at a subacute stage after stroke. The efficiency of very early intensive PT (within the 2 first weeks) has…
Objective Pisa syndrome (PS) is a common abnormal posture of the trunk in Parkinson disease which is defined as a lateral flexion of the spine in the coronal plane and/or…
Objective Bradykinesia in Parkinson’s disease (PD) predominates in large movements. Traditional assessments use the UPDRS, a subjective and ordinal tool that does not rate movement scaling (hypometria). We have measured…
Objective Micrographia and bradygraphia are classic features of Parkinson’s disease (PD). However, the relevance of quantifying them in the clinical exam with pen and paper is unclear. Materials/patients and methods…
Objective Translation and cultural adaptation of the ASES (arthritis self-efficacy scale) in French, which is a self-assessment questionnaire, composed of 20 questions divided in 3 domains: pain control, function and…
Objective To take care of postural disorders is a major issue in Parkinson’s disease (PD). We present a documented observation suggesting the existence of a biased representation of verticality in…
Objective The high-level mobility assessment tool (HiMAT) was developed to quantify balance and mobility problems after traumatic brain injury (TBI). The revised HiMAT is valid for people with neurological diseases….
